Swedish Orphan Biovitrum AB (publ) (SOBI) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.028x

Based on the latest financial reports, Swedish Orphan Biovitrum AB (publ) (SOBI) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr1.13 Billion ≈ $121.18 Million USD) by net assets (Skr40.38 Billion ≈ $4.35 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Swedish Orphan Biovitrum AB (publ) fund operations to measure how many days the company can operate on defensive assets alone.

Swedish Orphan Biovitrum AB (publ) - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Swedish Orphan Biovitrum AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Swedish Orphan Biovitrum AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Swedish Orphan Biovitrum AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sprott Physical Gold Trust TO:PHYS	-0.002x
Atlassian Corp Plc NASDAQ:TEAM	0.646x
Jiangxi Ganfeng Lithium Co Ltd SHE:002460	-0.016x
Joint Stock Company Kaspi.kz NASDAQ:KSPI	-0.507x
Evergreen Marine Corp Taiwan Ltd TW:2603	0.044x
JIO Financial Services Ltd NSE:JIOFIN	0.000x
PTC Inc NASDAQ:PTC	0.083x
Banco de Sabadell S.A MC:SAB	0.018x

Annual Cash Flow Conversion Efficiency for Swedish Orphan Biovitrum AB (publ) (2002–2025)

The table below shows the annual cash flow conversion efficiency of Swedish Orphan Biovitrum AB (publ) from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Swedish Orphan Biovitrum AB (publ) (SOBI) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr37.72 Billion ≈ $4.06 Billion	Skr8.56 Billion ≈ $921.62 Million	0.227x	+23.82%
2024-12-31	Skr40.30 Billion ≈ $4.34 Billion	Skr7.39 Billion ≈ $795.07 Million	0.183x	+38.91%
2023-12-31	Skr33.87 Billion ≈ $3.64 Billion	Skr4.47 Billion ≈ $481.04 Million	0.132x	-24.95%
2022-12-31	Skr26.52 Billion ≈ $2.85 Billion	Skr4.67 Billion ≈ $502.03 Million	0.176x	-25.40%
2021-12-31	Skr23.20 Billion ≈ $2.50 Billion	Skr5.47 Billion ≈ $588.66 Million	0.236x	-8.64%
2020-12-31	Skr20.21 Billion ≈ $2.17 Billion	Skr5.21 Billion ≈ $561.11 Million	0.258x	+20.22%
2019-12-31	Skr16.93 Billion ≈ $1.82 Billion	Skr3.63 Billion ≈ $391.08 Million	0.215x	-7.17%
2018-12-31	Skr9.04 Billion ≈ $972.86 Million	Skr2.09 Billion ≈ $224.95 Million	0.231x	+16.23%
2017-12-31	Skr6.70 Billion ≈ $721.08 Million	Skr1.33 Billion ≈ $143.45 Million	0.199x	+210.66%
2016-12-31	Skr5.35 Billion ≈ $576.21 Million	Skr342.86 Million ≈ $36.90 Million	0.064x	-40.80%
2015-12-31	Skr4.69 Billion ≈ $504.65 Million	Skr507.20 Million ≈ $54.58 Million	0.108x	+109.27%
2014-12-31	Skr4.52 Billion ≈ $486.73 Million	Skr233.77 Million ≈ $25.16 Million	0.052x	+32.97%
2013-12-31	Skr4.77 Billion ≈ $513.25 Million	Skr185.39 Million ≈ $19.95 Million	0.039x	-53.62%
2012-12-31	Skr4.84 Billion ≈ $520.65 Million	Skr405.47 Million ≈ $43.64 Million	0.084x	+304.14%
2011-12-31	Skr4.96 Billion ≈ $534.14 Million	Skr102.93 Million ≈ $11.08 Million	0.021x	+141.86%
2010-12-31	Skr4.34 Billion ≈ $467.31 Million	Skr-215.10 Million ≈ $-23.15 Million	-0.050x	-213.80%
2009-12-31	Skr1.35 Billion ≈ $145.58 Million	Skr58.88 Million ≈ $6.34 Million	0.044x	+111.04%
2008-12-31	Skr1.28 Billion ≈ $138.28 Million	Skr-506.49 Million ≈ $-54.51 Million	-0.394x	-2156.87%
2007-12-31	Skr1.45 Billion ≈ $156.34 Million	Skr-25.37 Million ≈ $-2.73 Million	-0.017x	+72.56%
2006-12-31	Skr1.38 Billion ≈ $148.70 Million	Skr-87.96 Million ≈ $-9.47 Million	-0.064x	-66.41%
2005-12-31	Skr1.71 Billion ≈ $183.77 Million	Skr-65.32 Million ≈ $-7.03 Million	-0.038x	+62.02%
2004-12-31	Skr2.08 Billion ≈ $223.37 Million	Skr-209.03 Million ≈ $-22.50 Million	-0.101x	-127.94%
2003-12-31	Skr2.10 Billion ≈ $225.57 Million	Skr755.60 Million ≈ $81.31 Million	0.360x	+6368.45%
2002-12-31	Skr1.73 Billion ≈ $185.73 Million	Skr9.62 Million ≈ $1.04 Million	0.006x	--

About Swedish Orphan Biovitrum AB (publ)

ST:SOBI Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$16.19 Billion

Skr150.44 Billion SEK

Market Cap Rank

#1532 Global

#22 in Sweden

Share Price

Skr435.00

Change (1 day)

+0.00%

52-Week Range

Skr264.40 - Skr447.20

All Time High

Skr447.20